Chinook Therapeutics Inc (KDNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
| Sales | 17,239 | 50,681 | 72,979 | 13,389 | 828 |
| Gross Profit | 17,239 | 50,681 | 72,979 | 13,389 | 828 |
| Operating Expenses | 123,692 | 122,544 | 86,543 | 32,507 | 15,364 |
| Operating Income | -106,453 | -71,863 | -13,564 | -19,118 | -14,536 |
| Interest Expense | 0 | 0 | 0 | 2,395 | 1,371 |
| Other Income | 3,226 | 2,179 | -25,744 | 4,499 | -147 |
| Pre-tax Income | -103,227 | -69,684 | -39,308 | -17,014 | -16,054 |
| Income Tax | -11,364 | 21,464 | -99 | N/A | N/A |
| Net Income Continuous | -91,863 | -91,148 | -39,209 | -17,014 | -16,054 |
| Net Income | $-91,863 | $-91,148 | $-39,209 | $-17,014 | $-16,054 |
| EPS Basic Total Ops | -6.30 | -7.00 | -4.40 | -265.30 | -279.00 |
| EPS Basic Continuous Ops | -6.30 | -6.99 | -4.39 | -265.02 | -278.72 |
| EPS Diluted Total Ops | -6.30 | -7.00 | -4.40 | -265.30 | -279.00 |
| EPS Diluted Continuous Ops | -6.30 | -6.99 | -4.39 | -265.02 | -278.72 |
| EPS Diluted Before Non-Recurring Items | -7.10 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-101,847 | $-67,480 | $-12,116 | $-18,878 | $-14,407 |